| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 409.13B | 423.43B | 387.78B | 351.86B | 310.82B | 300.27B |
| Gross Profit | 114.13B | 118.89B | 109.42B | 99.95B | 89.87B | 77.10B |
| EBITDA | 24.88B | 26.45B | 24.84B | 21.83B | 20.86B | 19.36B |
| Net Income | 12.36B | 12.68B | 12.38B | 10.68B | 9.61B | 9.19B |
Balance Sheet | ||||||
| Total Assets | 215.71B | 221.38B | 202.19B | 185.82B | 170.70B | 154.44B |
| Cash, Cash Equivalents and Short-Term Investments | 21.47B | 19.85B | 17.83B | 17.03B | 15.58B | 11.79B |
| Total Debt | 40.77B | 43.70B | 36.77B | 34.51B | 35.83B | 29.70B |
| Total Liabilities | 101.02B | 100.78B | 92.26B | 85.85B | 79.39B | 70.79B |
| Stockholders Equity | 114.68B | 120.59B | 109.92B | 99.97B | 91.30B | 83.65B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.27B | 4.72B | 3.80B | -988.00M | 724.00M |
| Operating Cash Flow | 0.00 | 20.93B | 22.69B | 21.06B | 15.62B | 17.06B |
| Investing Cash Flow | 0.00 | -22.77B | -21.72B | -16.23B | -15.93B | -18.48B |
| Financing Cash Flow | 0.00 | 3.78B | -165.00M | -3.38B | 4.10B | 5.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥114.08B | 11.71 | ― | 1.92% | 2.30% | 26.52% | |
74 Outperform | ¥56.03B | 19.57 | ― | 3.31% | 4.92% | 19.73% | |
71 Outperform | ¥94.15B | 11.65 | ― | 1.47% | 7.75% | -1.68% | |
71 Outperform | ¥72.45B | 11.40 | ― | 1.34% | 20.50% | 10.77% | |
69 Neutral | ¥160.05B | 13.26 | ― | 1.64% | 10.13% | 23.77% | |
69 Neutral | ¥228.58B | 19.90 | ― | 2.43% | 4.48% | 13.17% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |